SB986 - State Board of Pharmacy - Prohibition on Discrimination Against 340B Drug Distribution
Maryland - 2024 Regular Session
Introduced byClarence K. Lam
Last updated 6 months ago
1 Co-Sponsor
Prohibiting a 340B manufacturer from taking certain direct or indirect actions to limit or restrict the acquisition or delivery of a 340B drug; making a violation of the Act an unfair, abusive, or deceptive trade practice within the meaning of the Consumer Protection Act; and requiring the Maryland Prescription Drug Affordability Board to conduct a study of the 340B Program and report its findings and recommendations to the Senate Finance Committee and the House Health and Government Operations Committee on or before July 1, 2026.
STATUS
Engrossed
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity nowError
You must be a resident or registered voter in this state.